Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2013Urologia InternationalisOpen Access

Efficacy and Safety of Tadalafil Monotherapy for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Meta-Analysis

View Full Paper
Ask AI
Bookmark
Share

Authors

YDYang DongHainan UniversityZSZhenduo ShiJiangsu UniversityGWGang WangFujian Medical University

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Dong et al. (2013) studied this question.

synapsesocial.com/papers/6a7c97caa42cae215d7ccd20https://doi.org/10.1159/000351405
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Characterization and Functional Role of Androgen-Dependent PDE5 Activity in the Bladder2006 · 223 citations
  2. 2Long-Term Safety and Efficacy of Tadalafil 5 mg Dosed Once Daily in Men with Erectile Dysfunction2008 · 92 citations
  3. 3Phosphodiesterase-5 inhibitors and benign prostatic hyperplasia2009 · 56 citations
  4. 4Tadalafil 2.5 or 5 mg Administered Once Daily for 12 Weeks in Men with Both Erectile Dysfunction and Signs and Symptoms of Benign Prostatic Hyperplasia: Results of a Randomized, Placebo-Controlled, Double-Blind Study2011 · 139 citations
  5. 5Tadalafil Administered Once Daily for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Dose Finding Study2008 · 292 citations